ArticleClinical and experimental medicine2024

TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database.

Xin'an Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.